The leading refractive surgery stories on Healio/OSN so far this year include a guest blogger examining the benefits of in-office premium procedures.
Read the best-performing articles from the first weeks of 2021 below.
Ocuphire initiates phase 3 study of Nyxol for night vision disturbances
Patient recruitment and screening are underway in the LYNX-1 phase 3 registration study to investigate the safety and efficacy of Nyxol for night vision disturbances. Read more.
Pinpointing the center: Effective centration of advanced IOLs
IOLs must be centered precisely to achieve optimal refractive outcomes
Uncategorized